SMS PHARMACEUTICALS Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹210 Cr | ₹242 Cr | ₹196 Cr | ₹248 Cr | ₹173 Cr | ₹197 Cr | ₹164 Cr | ₹246 Cr |
| Expenses | ₹167 Cr | ₹194 Cr | ₹157 Cr | ₹207 Cr | ₹140 Cr | ₹165 Cr | ₹131 Cr | ₹212 Cr |
| Operating Income | ₹44 Cr | ₹48 Cr | ₹39 Cr | ₹41 Cr | ₹33 Cr | ₹31 Cr | ₹34 Cr | ₹34 Cr |
| Other Income | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Interest | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr |
| Depreciation | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr |
| Profit Before Tax | ₹31 Cr | ₹34 Cr | ₹24 Cr | ₹29 Cr | ₹22 Cr | ₹20 Cr | ₹22 Cr | ₹22 Cr |
| Profit After Tax | ₹23 Cr | ₹25 Cr | ₹19 Cr | ₹20 Cr | ₹17 Cr | ₹14 Cr | ₹16 Cr | ₹16 Cr |
| EPS | ₹2.51 | ₹2.70 | ₹2.31 | ₹2.29 | ₹2.15 | ₹1.67 | ₹1.95 | ₹2.04 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SMS PHARMACEUTICALS | -0.8% | -6.1% | 56% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -1.3% | -3.5% |
| DIVIS LABORATORIES | 1.9% | -6.7% | 0.4% |
| CIPLA | 1.3% | -8.5% | -7.3% |
| TORRENT PHARMACEUTICALS | 1.3% | 2.9% | 28.7% |
| DR REDDYS LABORATORIES | 1.3% | 3.8% | 4.5% |
| MANKIND PHARMA | -0.9% | -5.8% | -18.4% |
| ZYDUS LIFESCIENCES | -2% | -0.9% | -5.2% |
| LUPIN | 0.5% | 1.1% | 4.2% |
SMS PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -13.19 % |
| Y-o-Y | 21.40 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹210 Cr | -13.19 | |
| Sep2025 | ₹242 Cr | 23.66 | |
| Jun2025 | ₹196 Cr | -21.01 | |
| Mar2025 | ₹248 Cr | 43.17 | |
| Dec2024 | ₹173 Cr | -11.89 | |
| Sep2024 | ₹197 Cr | 19.64 | |
| Jun2024 | ₹164 Cr | -33.10 | |
| Mar2024 | ₹246 Cr | - | |
SMS PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -9.76 % |
| Y-o-Y | 31.42 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹44 Cr | -9.76 | |
| Sep2025 | ₹48 Cr | 22.86 | |
| Jun2025 | ₹39 Cr | -3.52 | |
| Mar2025 | ₹41 Cr | 22.87 | |
| Dec2024 | ₹33 Cr | 5.55 | |
| Sep2024 | ₹31 Cr | -6.11 | |
| Jun2024 | ₹34 Cr | -0.32 | |
| Mar2024 | ₹34 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 3.96 % |
| Y-o-Y | 8.25 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 20.74% | 3.96 | |
| Sep2025 | 19.95% | -0.65 | |
| Jun2025 | 20.08% | 22.14 | |
| Mar2025 | 16.44% | -14.20 | |
| Dec2024 | 19.16% | 19.82 | |
| Sep2024 | 15.99% | -21.54 | |
| Jun2024 | 20.38% | 48.98 | |
| Mar2024 | 13.68% | - | |
SMS PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -7.73 % |
| Y-o-Y | 35.77 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹23 Cr | -7.73 | |
| Sep2025 | ₹25 Cr | 34.28 | |
| Jun2025 | ₹19 Cr | -6.82 | |
| Mar2025 | ₹20 Cr | 17.59 | |
| Dec2024 | ₹17 Cr | 23.22 | |
| Sep2024 | ₹14 Cr | -15.35 | |
| Jun2024 | ₹16 Cr | 2.00 | |
| Mar2024 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 6.27 % |
| Y-o-Y | 11.88 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 11.02 % | 6.27 | |
| Sep2025 | 10.37 % | 8.59 | |
| Jun2025 | 9.55 % | 18.05 | |
| Mar2025 | 8.09 % | -17.87 | |
| Dec2024 | 9.85 % | 39.72 | |
| Sep2024 | 7.05 % | -29.22 | |
| Jun2024 | 9.96 % | 52.53 | |
| Mar2024 | 6.53 % | - | |
SMS PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -7.04 % |
| Y-o-Y | 16.74 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹2.51 | -7.04 | |
| Sep2025 | ₹2.7 | 16.88 | |
| Jun2025 | ₹2.31 | 0.87 | |
| Mar2025 | ₹2.29 | 6.51 | |
| Dec2024 | ₹2.15 | 28.74 | |
| Sep2024 | ₹1.67 | -14.36 | |
| Jun2024 | ₹1.95 | -4.41 | |
| Mar2024 | ₹2.04 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD